High Court Criticises Food Safety Body Over Restaurant Licence Suspensions

The Bombay High Court has sharply criticised the Maharashtra Food and Drugs Administration (FDA) after the agency suspended the operating licences of five restaurants located within the Mumbai Cricket Association's premises. The FDA is currently headed by Tukaram Mundhe.

During the hearing, the judges posed a pointed rhetorical question to the FDA, asking, "Do you feel you are a lord?" and questioning whether the agency believed it could act without accountability. The remark reflected the court's broader concern about how the suspension was handled.

According to the court, the FDA's decision to suspend the licences was made in a mechanical fashion, suggesting a lack of careful consideration or individual assessment of each establishment before such a serious step was taken. The judges emphasised that regulatory bodies, despite holding legitimate authority over licensing and safety enforcement, are not exempt from acting reasonably and within the bounds of proper procedure.

The court's intervention underscores a recurring theme in judicial oversight of administrative bodies: that power granted to enforce rules does not equate to unchecked discretion. Government agencies, the court implied, must justify their actions with clear reasoning rather than applying blanket measures.

Following the High Court's rebuke, the FDA reversed course and revokes the suspension affecting all five eateries. This decision allows the restaurants to resume normal business operations immediately, restoring their legal standing to serve customers at the cricket association's premises.

The episode is likely to draw attention to how regulatory enforcement is carried out in Maharashtra, particularly regarding the balance between ensuring food safety standards and respecting the due process rights of businesses. It also raises broader questions about accountability mechanisms available to businesses that believe they have been treated unfairly by government bodies.

While the summary does not detail the specific reasons behind the original suspension or the exact grounds cited by the FDA, the High Court's strong language indicates that the judiciary found the agency's approach lacking in fairness or thorough justification.